Your session is about to expire
← Back to Search
Vacuum System
SOMAVAC® 100 Sustained Vacuum System for Seroma
N/A
Waitlist Available
Led By Martin D Fleming, MD
Research Sponsored by SOMAVAC Medical Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1week - 1year
Awards & highlights
Study Summary
This study is evaluating whether a new device may help reduce the amount of time it takes to remove cancerous tissue.
Eligible Conditions
- Seroma
- Hematoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week - 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week - 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Surgical site related complications
Time with drains
Secondary outcome measures
Amount of fluid collected
Patient reported usability of the suction device
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention
All participants receive the SOMAVAC® 100 Sustained Vacuum System
Find a Location
Who is running the clinical trial?
SOMAVAC Medical SolutionsLead Sponsor
University of TennesseeOTHER
188 Previous Clinical Trials
141,612 Total Patients Enrolled
University of Tennessee Health Science CenterOTHER
48 Previous Clinical Trials
25,075 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger